268 related articles for article (PubMed ID: 14678954)
1. Gastric inhibitory polypeptide does not inhibit gastric emptying in humans.
Meier JJ; Goetze O; Anstipp J; Hagemann D; Holst JJ; Schmidt WE; Gallwitz B; Nauck MA
Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E621-5. PubMed ID: 14678954
[TBL] [Abstract][Full Text] [Related]
2. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
[TBL] [Abstract][Full Text] [Related]
3. Glucose dependent insulinotropic polypeptide (GIP) infused intravenously is insulinotropic in the fasting state in type 2 (non-insulin dependent) diabetes mellitus.
Jones IR; Owens DR; Luzio S; Hayes TM
Horm Metab Res; 1989 Jan; 21(1):23-6. PubMed ID: 2647605
[TBL] [Abstract][Full Text] [Related]
4. Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia.
Toft-Nielsen M; Madsbad S; Holst JJ
Diabetologia; 1998 Oct; 41(10):1180-6. PubMed ID: 9794105
[TBL] [Abstract][Full Text] [Related]
5. Effect of Miglitol (Bay m1099), a new alpha-glucosidase inhibitor, on glucose, insulin, C-peptide and GIP responses to an oral sucrose load in patients with post-prandial hypoglycaemic symptoms.
Renard E; Parer-Richard C; Richard JL; Jureidini S; Orsetti A; Mirouze J
Diabete Metab; 1991; 17(3):355-62. PubMed ID: 1884880
[TBL] [Abstract][Full Text] [Related]
6. The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal.
Frost GS; Brynes AE; Dhillo WS; Bloom SR; McBurney MI
Eur J Clin Nutr; 2003 Feb; 57(2):293-8. PubMed ID: 12571662
[TBL] [Abstract][Full Text] [Related]
7. Influence of gastric inhibitory polypeptide on pentagastrin-stimulated gastric acid secretion in patients with type 2 diabetes and healthy controls.
Meier JJ; Nauck MA; Kask B; Holst JJ; Deacon CF; Schmidt WE; Gallwitz B
World J Gastroenterol; 2006 Mar; 12(12):1874-80. PubMed ID: 16609993
[TBL] [Abstract][Full Text] [Related]
8. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
Nauck M; Schmidt WE; Ebert R; Strietzel J; Cantor P; Hoffmann G; Creutzfeldt W
J Clin Endocrinol Metab; 1989 Sep; 69(3):654-62. PubMed ID: 2668324
[TBL] [Abstract][Full Text] [Related]
9. Gastric emptying and release of incretin hormones after glucose ingestion in humans.
Schirra J; Katschinski M; Weidmann C; Schäfer T; Wank U; Arnold R; Göke B
J Clin Invest; 1996 Jan; 97(1):92-103. PubMed ID: 8550855
[TBL] [Abstract][Full Text] [Related]
10. Effect of euglycaemic hyperinsulinaemia on gastric emptying and gastrointestinal hormone responses in normal subjects.
Kong MF; King P; Macdonald IA; Blackshaw PE; Perkins AC; Armstrong E; Buchanan KD; Tattersall RB
Diabetologia; 1998 Apr; 41(4):474-81. PubMed ID: 9562353
[TBL] [Abstract][Full Text] [Related]
11. Effects of nitric oxide on antral motility and gastric emptying in humans.
Konturek JW; Thor P; Domschke W
Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):97-102. PubMed ID: 7712314
[TBL] [Abstract][Full Text] [Related]
12. Suppression of postprandial glucose, insulin, C-peptide, and glucose-dependent insulinotropic peptide (GIP) in man by oral administration of a prostaglandin analogue (enprostil).
Schwartz KE; Zaro B; Reynolds J; Duffy J; Saito T; Hunt JS; Sevelius H
Horm Metab Res; 1988 Oct; 20(10):637-40. PubMed ID: 3146539
[TBL] [Abstract][Full Text] [Related]
13. The effect of insulin deprivation on fasting levels of 5000 dalton gastric inhibitory polypeptide in type 1 (insulin-dependent) diabetics.
Krarup T; Madsbad S; Regeur L; Alberti KG; Faber OK; Kurtz A
Diabete Metab; 1985 Dec; 11(6):364-7. PubMed ID: 3910488
[TBL] [Abstract][Full Text] [Related]
14. GIP and insulin release in relation to gastric emptying of a mixed meal in man.
Fried M; Mayer EA; Bloom SR; Taylor IL; Meyer JH
Regul Pept; 1989 Dec; 26(3):305-12. PubMed ID: 2695982
[TBL] [Abstract][Full Text] [Related]
15. Effect of soya bean oil on symptoms, gastric emptying and gut hormone release in patients with postvagotomy symptoms.
Lawaetz O; Bloom SR; Stimpel H; Siemssen OJ
Ann Chir Gynaecol; 1986; 75(6):308-13. PubMed ID: 3555275
[TBL] [Abstract][Full Text] [Related]
16. A supplementary infusion of glucose-dependent insulinotropic polypeptide (GIP) with a meal does not significantly improve the beta cell response or glucose tolerance in type 2 diabetes mellitus.
Jones IR; Owens DR; Vora J; Luzio SD; Hayes TM
Diabetes Res Clin Pract; 1989 Nov; 7(4):263-9. PubMed ID: 2693029
[TBL] [Abstract][Full Text] [Related]
17. Effect of exogenous or endogenous gastric inhibitory polypeptide (GIP) on plasma triglyceride responses in rats.
Ebert R; Nauck M; Creutzfeldt W
Horm Metab Res; 1991 Nov; 23(11):517-21. PubMed ID: 1816061
[TBL] [Abstract][Full Text] [Related]
18. Effect of calcitonin on gastric emptying and on postprandial gastrin and insulin release in patients with type I gastric ulcer.
Jonderko G; Jonderko K; Gołab T
Neth J Med; 1990 Aug; 37(1-2):11-6. PubMed ID: 2215826
[TBL] [Abstract][Full Text] [Related]
19. The effect of somatostatin on fasting and postprandial plasma GIP, serum insulin, and blood glucose in man.
Jorde R; Waldum HL; Burhol PG; Lygren I; Schulz TB; Florholmen J; Jenssen TG
Scand J Gastroenterol; 1981; 16(1):113-9. PubMed ID: 6112787
[TBL] [Abstract][Full Text] [Related]
20. Circulating gastrointestinal hormone abnormalities in patients with severe idiopathic constipation.
van der Sijp JR; Kamm MA; Nightingale JM; Akkermans LM; Ghatei MA; Bloom SR; Jansen JB; Lennard-Jones JE
Am J Gastroenterol; 1998 Aug; 93(8):1351-6. PubMed ID: 9707064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
